Pacific Biosciences Of California (PACB) FCF Margin Growth (5y) (2015 - 2026)
Pacific Biosciences Of California (PACB) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn |
| 10 | Pacific Biosciences Of California | 420.50 Mn | 144.54 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,733.00 |
| Dec 31, 2025 | 817.00 |
| Sep 30, 2025 | 4,769.00 |
| Jun 30, 2025 | 6,591.00 |
| Mar 31, 2025 | -60,473.00 |
| Dec 31, 2024 | -1,667.00 |
| Sep 30, 2024 | -2,924.00 |
| Jun 30, 2024 | -8,098.00 |
| Mar 31, 2024 | -4,326.00 |
| Dec 31, 2023 | -458.00 |
| Sep 30, 2023 | -3,995.00 |
| Jun 30, 2023 | -1,904.00 |
| Mar 31, 2023 | -15,425.00 |
| Dec 31, 2022 | -15,409.00 |
| Sep 30, 2022 | -11,851.00 |
| Jun 30, 2022 | -10,110.00 |
| Mar 31, 2022 | -17,158.00 |
| Dec 31, 2021 | -3,546.00 |
| Jun 30, 2021 | 4,806.00 |
| Mar 31, 2021 | 2,729.00 |